Education
About Us
Working with TipRanks
Follow Us
Elevance Health, Inc. (ELV)
:ELV
Total Valuation
Elevance Health has a market cap or net worth of $78.21B. The enterprise value is $65.18B.
Market Cap$78.21B
Enterprise Value$65.18B
Share Statistics
Elevance Health has 222,238,770 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding222,238,770
Owned by Insiders0.15%
Owned by Institutions28.14%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 6.44%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.44%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.70M
Profits Per Employee57.30K
Employee Count104,200
Asset Turnover1.51
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 14.4. Elevance Health’s PEG ratio is 8.48.
PE Ratio14.4
PS Ratio0.49
PB Ratio2.08
Price to Fair Value2.08
Price to FCF18.87
Price to Operating Cash Flow16.62
PEG Ratio8.48
Income Statement
In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 25.81.
Revenue176.81B
Gross Profit176.81B
Operating Income7.90B
Pretax Income7.90B
Net Income5.98B
EBITDA10.48B
Earnings Per Share (EPS)25.81
Cash Flow
In the last 12 months, operating cash flow was 4.91B and capital expenditures -1.15B, giving a free cash flow of 3.77B billion.
Operating Cash Flow4.91B
Free Cash Flow3.77B
Free Cash Flow per Share16.95
Dividends & Yields
Elevance Health pays an annual dividend of $1.71, resulting in a dividend yield of 1.94%
Dividend Per Share$1.71
Dividend Yield1.94%
Payout Ratio44.59%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change-2.12%
50-Day Moving Average334.45
200-Day Moving Average353.47
Relative Strength Index (RSI)61.86
Average Volume (3m)1.53M
Important Dates
Elevance Health upcoming earnings date is Jan 28, 2026, Before Open (Confirmed).
Last Earnings DateOct 21, 2025
Next Earnings DateJan 28, 2026
Ex-Dividend Date―
Financial Position
Elevance Health as a current ratio of 2.01, with Debt / Equity ratio of 2.11%
Current Ratio2.01
Quick Ratio2.01
Debt to Market Cap0.36
Net Debt to EBITDA2.19
Interest Coverage Ratio6.67
Taxes
In the past 12 months, Elevance Health has paid 1.93B in taxes.
Income Tax1.93B
Effective Tax Rate0.24
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 10.38, with an EV/FCF ratio of 23.91.
EV to Sales0.62
EV to EBITDA10.38
EV to Free Cash Flow23.91
EV to Operating Cash Flow18.74
Balance Sheet
Elevance Health has $35.00B in cash and marketable securities with $32.10B in debt, giving a net cash position of $2.89B billion.
Cash & Marketable Securities$35.00B
Total Debt$32.10B
Net Cash$2.89B
Net Cash Per Share$13.02
Tangible Book Value Per Share$4.53
Margins
Gross margin is 77.66%, with operating margin of 4.47%, and net profit margin of 3.38%.
Gross Margin77.66%
Operating Margin4.47%
Pretax Margin4.47%
Net Profit Margin3.38%
EBITDA Margin5.93%
EBIT Margin5.14%
Analyst Forecast
The average price target for Elevance Health is $390.69, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$390.69
Price Target Upside11.02% Upside
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast11.96%
EPS Growth Forecast-11.11%